OVID — OVID THERAPEUTICS INC

Ownership history in Stonepine Capital Management, LLC  ·  8 quarters on record

This page tracks every 13F SEC filing in which Stonepine Capital Management, LLC reported a position in OVID THERAPEUTICS INC (OVID). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
5.9% (2021 Q4)
Avg. % of fund
4.0%
First filed
2021 Q1
Last filed
2025 Q4
Quarters held
8
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 102,367 -1,438,304 -93.4% 0.12% $167K $1.63
2022 Q3 REDUCED 1,540,671 -1,947,257 -55.8% 1.27% $2.8M $1.84
2022 Q2 REDUCED 3,487,928 -730,141 -17.3% 3.49% $7.5M $2.15
2022 Q1 ADDED 4,218,069 +211,884 +5.3% 5.49% $13.2M $3.14
4 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    OVID price (monthly, adj. close)

Other funds also holding OVID

As of 2025 Q4 — sorted by position size

Ally Bridge Group (NY) LLC 3Y 3.03% TLS Advisors LLC 3Y 0.98% Saturn V Capital Management LP 3Y 0.75% Affinity Asset Advisors, LLC 3Y 0.66% ADAR1 Capital Management, LLC 0.51% Sio Capital Management, LLC 3Y 7Y 0.37% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 0.18% Velan Capital Investment Management LP 3Y 0.15% AWM Investment Company, Inc. 3Y 7Y 0.14% EVENTIDE ASSET MANAGEMENT, LLC 3Y 7Y 0.11%
← Back to Stonepine Capital Management, LLC Holdings